For patients with acne who have not responded to topical treatments, consider referring them to a consultant dermatologist-led team or a nationally accredited GP with an Extended Role (GPwER) working within a pathway, especially if they have moderate to severe acne that has not responded to two completed courses of treatment NICE NG198.
If the acne is severe and resistant to standard therapy, consider oral isotretinoin after assessing the patient's suitability, following the MHRA guidance on safety measures NICE NG198.
In cases of refractory acne, review treatment options and consider another 12-week course of an appropriate treatment, or refer to specialist care if there is no response NICE CKS.
Additionally, discuss the possibility of maintenance therapy after initial response, which may include topical retinoids or combinations, to prevent relapse NICE NG198.